Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1 Chiachen ChenYuan-Ching Chang Ing-Cherng Guo Preclinical study 03 June 2006 Pages: 121 - 132
AFPep: an anti-breast cancer peptide that is orally active James A. BennettLori DeFreestThomas T. Andersen Preclinical study 15 March 2006 Pages: 133 - 141
Population-based mammography screening results in substantial savings in treatment costs for fatal breast cancer Lea KauhavaPirjo Immonen-RäihäPekka J. Klemi Epidemiology 15 March 2006 Pages: 143 - 150
Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer Lukas A. HeflerChristoph GrimmRobert Zeillinger Preclinical study 15 March 2006 Pages: 151 - 155
Interrelationships between serum leptin, IGF-1, IGFBP3, C-peptide and prolactin and breast cancer risk in young women Roni T. FalkLouise A. BrintonJanet R. Daling Epidemiology 24 February 2006 Pages: 157 - 165
Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer Harriet JohanssonBernardo BonanniAndrea Decensi Clinical trial 15 March 2006 Pages: 167 - 172
No nodal cutoff in node-positive breast cancer women treated with mastectomy V Vinh-HungG Storme Epidemiology 15 March 2006 Pages: 173 - 178
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients Erich F. SolomayerSven BeckerTanja N. Fehm Preclinical study 22 March 2006 Pages: 179 - 184
Assessing the status of axillary sentinel lymph nodes of breast carcinoma patients by a real-time quantitative RT-PCR assay for mammaglobin 1 mRNA Patrizia Dell’OrtoMaria Olivia BiasiGiuseppe Viale Preclinical study 15 March 2006 Pages: 185 - 190
Identification of BAF57 mutations in human breast cancer cell lines Evangelos KiskinisJuana M. García-PedreroBorja Belandia Preclinical study 15 March 2006 Pages: 191 - 198
Fruits, vegetables, and micronutrient intake in relation to breast cancer survival Brian N. FinkMia M. GaudetMarilie D. Gammon Epidemiology 15 March 2006 Pages: 199 - 208
XPD Common Variants and their Association with Melanoma and Breast Cancer Risk T. DębniakR.J. Scottand J. Lubinski Epidemiology 10 May 2006 Pages: 209 - 215
Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52 James N. IngleVera J. SumanEdith A. Perez Clinical trial 15 March 2006 Pages: 217 - 222
High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer Paul N. SpanVivianne C.G. Tjan-HeijnenFred C.G.J. Sweep Preclinical study 16 March 2006 Pages: 223 - 230
Expression of “Spot 14” (THRSP) predicts disease free survival in invasive breast cancer: immunohistochemical analysis of a new molecular marker Wendy A. WellsGary N. SchwartzWilliam B. Kinlaw Preclinical study 22 March 2006 Pages: 231 - 240
